CEMI News and Press, Chembio Diagnostics Inc. From 05/11/20

HAUPPAUGE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the closing of its previously announced public offering of 2,619,593 shares o...

MicroVision (NASDAQ: MVIS ) -24% . More news on: MicroVision, Inc., Vista Outdoor Inc., SG Blocks, Inc., Stocks on the move, , Read more ...

Chembio Diagnostics (NASDAQ: CEMI ) prices its public offering of ~2.3M common shares at $11.75 per share. More news on: Chembio Diagnostics, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

HAUPPAUGE, N.Y., May 07, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the pricing of its previously announced public offering of 2,338,468 shares o...

Portola Pharmaceuticals (NASDAQ: PTLA ) +131%  on being acquired for $18/share. More news on: Portola Pharmaceuticals, Inc., SG Blocks, Inc., MicroVision, Inc., Stocks on the move, , Read more ...

Chembio Diagnostics (NASDAQ: CEMI ) announced Q1 results after the close yesterday that missed views , but investors are reacting to its update on activities related to its DPP COVID-19 IgM/IgG blood test that it recently launched. Key developments: More news on: Chembio Diagnostics, In...

Chembio Diagnostics, Inc. (CEMI) Q1 2020 Earnings Conference Call May 4, 2020, 04:30 PM ET Company Participants Philip Taylor - IR Gail Page - Chairman Rick Eberly - President & CEO Neil Goldman - CFO Javan Esfandiari - Chief Product and Technology Officer Conference C...

Chembio Diagnostics (NASDAQ: CEMI ): Q1 GAAP EPS of -$0.29 misses by $0.06 . More news on: Chembio Diagnostics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended March 31, 2020. Recent Accomplishments & Highlights Atta...

HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has attained the CE Marking for its DPP COVID-19 System. The CE Marking represents the ability to co...